Skip to content

Line Blot Immunoassay for Autoantibodies (e.g., Antinuclear Antibodies, ANA)

Published: August 9, 2026Updated: August 16, 2026

This test detects specific antibodies in your blood that may be linked to certain autoimmune diseases, such as lupus or rheumatoid arthritis. It helps identify whether your immune system is mistakenly attacking healthy cells in your body.

Quick summary

["This test may help diagnose or monitor autoimmune conditions by checking for unusual antibodies in your blood."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
106942-6
Short code
CV2 IgG CSF Ql Line blot
Synonyms
CV2 IgG CSF Ql Line blot
Category
chemistry
Sample
csf
Container
Sterile tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
line-blot
CPT
82784
Specimen volume
1-2 mL
Stability
Immediate analysis required, Refrigerated: 1h
Hemolysis max
200
TAT
4–24 hours
Order
routine

What This Test Measures

The line blot immunoassay detects a range of autoantibodies, including common markers like antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA), and others that may signal autoimmune activity. The test uses a fluid sample (usually serum) to identify these antibodies by binding to specific targets on a membrane, creating visible lines if antibodies are present.

Why It’s Ordered

Your healthcare provider may order this test if you have symptoms like joint pain, fatigue, rash, or unexplained organ issues that could suggest an autoimmune condition. It’s also used to monitor known autoimmune diseases or screen for conditions like lupus, Sjögren’s syndrome, or mixed connective tissue disease.

Sample Collection and Preparation

A blood sample is typically drawn from a vein in your arm. The serum portion is separated and sent to the lab for testing. The line blot assay involves applying the serum to a membrane with immobilized antigens, allowing antibodies to bind if present.

Test Results and Interpretation

Results are qualitative (positive or negative) and may show multiple lines if multiple autoantibodies are detected. A positive result suggests a higher likelihood of an autoimmune condition, but further testing or clinical correlation is needed for diagnosis.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

ANA Line Blot Test

Frequently asked questions

Why might my doctor order this test?
Your doctor may order this test to investigate symptoms like persistent fatigue, joint swelling, or unexplained organ dysfunction. It helps rule out or confirm autoimmune diseases by detecting antibodies that target your body’s own tissues.
What does a positive result mean?
A positive result indicates the presence of autoantibodies, which may signal an autoimmune condition. However, not everyone with these antibodies has a disease, and additional tests or clinical evaluation are needed to diagnose or guide treatment.
How often should I get this test?
Your doctor will determine the frequency based on your symptoms, diagnosis, or treatment plan. Some patients may need monitoring every few months or annually, while others may only need it once.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy